相关实验视频
Updated: May 13, 2025

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.0K
在低氧条件下的共同培养中,白血病和食者之间的相互作用
Miriama Sikorová1, Pavel Klener1, Pavla Tonarová1
1Institute of Pathological Physiology, 1st Faculty of Faculty of Medicine, Charles University, U nemocnice 5, Prague, 128 53, Czech Republic.
BMC cancer
|April 14, 2025
概括
白血病细胞对骨髓模仿的反应不同;有些细胞在缺氧下与养细胞和糖解生长,突出了针对微环境相互作用的个性化疗法的需要.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 白血病的进展和治疗耐药性受到缺氧骨髓微环境的影响.
- 使用料细胞的共同培养模型模拟了白血病研究的骨髓利基.
- 这项研究研究了白血病细胞与纤维细胞和介酶干细胞在不同氧气水平下的相互作用.
研究的目的:
- 在正常和缺氧条件下,探索料细胞 (NHDF,hMSCs) 对白血病细胞系 (SD-1,UPF26K) 的影响.
- 了解共同种植如何影响白血病细胞的增殖,新陈代谢和活力.
- 分析模拟骨髓微环境中对养细胞的相互影响.
主要方法:
- 人类白血病细胞系 (SD-1,UPF26K) 与人类正常皮肤纤维细胞 (NHDF) 和人类介质干细胞 (hMSC) 的共同培养.
- 在正常和缺氧条件下共同培养的化.
- 评估细胞增殖,糖解活性和线粒体代谢.
主要成果:
- SD-1细胞在与食者共同培养时,表现出增强的增殖,糖解和活力,特别是在低氧状态下.
- UPF26K细胞在养器中表现出减少的增殖,而养细胞 (NHDF,hMSCs) 显示出增加的增殖和糖解,但线粒体代谢减少,因缺氧而放大.
- 缺氧显著影响了代谢变化,在某些共同培养组合中有利于糖解.
结论:
- 在低氧条件下利用糖解的白血病细胞从这些条件中获益最多,这表明代谢可塑性.
- 白血病细胞反应的异质性需要针对微环境相互作用和氧气水平的个性化治疗策略.
- 先进的共同培养模型,如球体,可以改善体外研究和针对白血病的新疗法测试.
相关概念视频
Hypoxia
845
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
845
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K

